US Patent Issued to HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL on Sept. 29 for "GLP-1 receptor agonist and composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,233, issued on Sept. 29, was assigned to HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL Co. LTD. (Zhejiang, China).

"GLP-1 receptor agonist and composition and use thereof" was invented by Wenqiang Zhai (Zhejiang, China), Zhimin Zhang (Zhejiang, China), Zhe Wang (Zhejiang, China), Hao Pan (Zhejiang, China), Liubin Guo (Zhejiang, China) and Qian Wang (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a GLP-1 receptor agonist compound and a composition and use thereof. The compound can be used for treating or preventing GLP-1 receptor-mediated diseases or disorders and related diseases or disorders."

The patent was filed on March ...